Fundamental Analysis
76 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +207.8% | +78.9% | 2 / 3 | -86.2% | +108.28 pp | +97.32 pp | +18.6% | 1.27 | 2.93 | 0,9 | −86,2% | 0,8 | +207,8% | 2.93 | 4.90 | −40,1% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 8 | 6 | 12 | |||||||
Valuation annotation:Price: 5.900 (close price on 2026-10-16)EPS (TTM): 2.012
Financial charts
1.Revenue & growth
VND bn0,93Q2/26
1.Revenue & growth
VND bn0,93Q2/26
2.Profit & growth
VND bn-0,44Q2/26
3.Profit mix (Penman)
VND bn9,22Q2/26
4.Margins & cost structure
%31.6%Q2/26
5.Returns & cash cycle
% · days-0.5%Q2/26
6.Earnings quality & cash
VND bn-136Q2/26
7.Asset structure
VND bn132Q2/26
8.Funding & debt health
VND bn · times132Q2/26
9.Revenue backlog
VND bn0,05Q2/26
10.Valuation
times · %3,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-85Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
14.4%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26